Joseph Pitts said...
Our medical innovation system is in jeopardy. Investment in life science area is declining at an alarming rate because of the escalating cost, time and risk of developing new drugs and devices.
Context
Pitts highlights concerns over declining investment in medical innovation due to regulatory issues.
02/14/2012